Search for: "Pharmaceutical Associates, Inc." Results 41 - 60 of 1,899
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Mar 2023, 6:07 pm by INFORRM
GoogleDecision Date: January 28, 2014 The Paris Tribunal of Commerce held Google Inc. responsible for not responding to an individual’s request to stop the association of his name with some words referring to his criminal past, in the “Google Suggest” function. [read post]
14 Feb 2023, 12:29 pm
Types of IP protection include: </span> </p> <p> <span style="display: initial;"> <br/> </span> </p> <h2> <span style="font-weight: bold; display: initial;"> Copyright Law </span> </h2> <p> <span style="display: initial;"> <br/> </span> </p> <p> … [read post]
12 Feb 2023, 8:35 pm by Patent Docs
February 14, 2023 - "Orange Book Listing Recent Developments -- Impact on Prosecution of Pharmaceutical U.S. [read post]
7 Feb 2023, 6:19 pm by Ben Vernia
The program is funded jointly by states and the federal government.Mallinckrodt ARD LLC, previously Questcor Pharmaceuticals Inc., paid $260 million to resolve separate allegations relating to its drug H.P. [read post]
7 Feb 2023, 12:00 pm by Bernard Bell
HHS was whether HHS could require drug makers to provide discounted pharmaceutical to any number of contract pharmacies a covered entity chose to use. [read post]
1 Feb 2023, 9:05 pm by renholding
  Pfizer was a major contributor to the level of healthcare M&A, announcing a number of deals, including its $11.6 acquisition of Biohaven Pharmaceuticals, $5.4 billion acquisition of Global Blood Therapeutics and $525 million acquisition of ReViral. [read post]
31 Jan 2023, 6:36 pm by admin
 Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
9 Jan 2023, 9:01 pm by renholding
Walgreens After more than seven years of litigation, Walgreens, Inc. [read post]
5 Jan 2023, 2:22 pm by Kevin LaCroix
The settlement ranks among the five largest securities settlements ever paid by a pharmaceutical manufacturer. [read post]
3 Jan 2023, 1:47 pm by Kevin LaCroix
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
5 Dec 2022, 1:03 pm by Edward T. Kang and Kandis Kovalsky
Fraudsters manipulate these programs, and the goodwill associated with them, to steal funds from the government to line their pockets. [read post]
27 Nov 2022, 8:10 pm by Patent Docs
Paul Berghoff of McDonnell Boehnen Hulbert & Berghoff LLP will moderate a panel consisting of Larry Coury of Regeneron Pharmaceuticals, Inc.; Stephanie Donahue of Sanofi; Henry Hadad of Bristol-Meyers Squibb Co.; and Stuart Watt of Amgen, Inc. that will discuss the issues and arguments concerning the current state of enablement and written description law and where the law may be headed. [read post]
Angela Colon-Mahoney is vice president of people and business services for Otsuka America Pharmaceutical, Inc., an industry leader in mental health. [read post]
26 Sep 2022, 7:59 pm by Cynthia Marcotte Stamer
The Equal Employment Opportunity Commission (“EEOC”) is suing pharmaceutical giant Lilly USA, LLC, for nationwide age discrimination by intentionally not hiring older workers for pharmaceutical sales representative positions based on their age from April 2017 to 2021. [read post]
8 Sep 2022, 5:55 am by Kaya van der Horst
Glock, Inc. (9th Cir. 2009), for example, plaintiffs argued that the gun manufacturers’ marketing practices constituted a public nuisance under California law because such conduct “significantly interferes with the public safety, health or peace. [read post]
Since President Biden issued his July 2021 Executive Order on Competition, the antitrust agencies have made broad policy statements promising more aggressive enforcement and have initiated a number of high-profile enforcement actions. [read post]